An improved linker which lacks chiral centers between a hydrophobic anchor for coupling to lipid-based particles and a targeting agent has suitable hydrophobic/hydrophilic properties for use in vivo.
[EN] VITRONECTIN RECEPTOR ANTAGONIST COMPOUNDS AND THEIR USE IN THE PREPARATION OF RADIOPHARMACEUTICALS<br/>[FR] COMPOSES DE L'ANTAGONISTE DU RECEPTEUR DE LA VITRONECTINE ET LEUR UTILISATION DANS LA PREPARATION DE PRODUITS RADIO PHARMACEUTIQUES
申请人:BRISTOL MYERS SQUIBB PHARMA CO
公开号:WO2004100996A1
公开(公告)日:2004-11-25
The present invention is directed to a compound comprising a thiol derivatized targeting moiety. The targeting moiety binds to a receptor which his upregulated during angiogenesis.